Optinose ( (OPTN) ) has released its Q3 earnings. Here is a breakdown of the information Optinose presented to its investors. Optinose is a ...

Amsellem covers the Healthcare sector, focusing on stocks such as Alkermes, Supernus Pharmaceuticals, and Corcept Therapeutics. Optinose has an analyst consensus of Moderate Buy, with a price target ...

Based on the one-year price targets offered by 4 analysts, the average target price for OptiNose Inc (NASDAQ:OPTN) is $3.50 with a high estimate of $5.00 and a low estimate of $3.00. The average ...

OptiNose OPTN is gearing up to announce its quarterly earnings on Tuesday, 2024-11-12. Here's a quick overview of what investors should know before the release. Analysts are estimating that ...

OptiNose (OPTN) reported break-even quarterly earnings per ... A quarter ago, it was expected that this specialty pharmaceutical company would post a loss of $0.08 per share when it actually produced ...

Dublin, Nov. 12, 2024 (GLOBE NEWSWIRE) -- The "Transmucosal Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 ...

Infinity Pharmaceuticals Inc. 0.00% $90.76 ...

Merck & Co. Inc.-2.13% $260.35B ...

BEIJING, Nov. 11, 2024 /PRNewswire/ -- Gan & Lee Pharmaceuticals (Gan & Lee, Shanghai Stock Exchange: 603087) announced that the results of the Phase 2b clinical study of GZR18 injection ...

The 21st century pharmaceutical and biotech sector has come a long way from its roots in 19th century pharmacy. pharmaphorum looks at its evolution over the centuries. The roots of the ...

There are certain phrases that Wachuka Gichohi finds difficult to hear after enduring four years of living with long COVID, marked by debilitating fatigue, pain, panic attacks and other symptoms ...

The U.S. Food and Drug Administration on Tuesday declined full approval for Intercept Pharmaceuticals' liver disease drug, raising questions about its future in the market. The U.S. Food and Drug ...